CVS Health Corporation $CVS Shares Sold by Vision Capital Management Inc.

Vision Capital Management Inc. cut its holdings in CVS Health Corporation (NYSE:CVS) by 20.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 32,043 shares of the pharmacy operator’s stock after selling 8,053 shares during the quarter. Vision Capital Management Inc.’s holdings in CVS Health were worth $2,746,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Kilter Group LLC purchased a new position in CVS Health in the 2nd quarter worth about $27,000. Sankala Group LLC acquired a new position in shares of CVS Health in the fourth quarter worth about $28,000. Global Trust Asset Management LLC increased its position in shares of CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 300 shares in the last quarter. J.Safra Asset Management Corp purchased a new position in shares of CVS Health in the second quarter worth approximately $30,000. Finally, Beaird Harris Wealth Management LLC raised its holdings in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 195 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the subject of a number of research analyst reports. Weiss Ratings lowered CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 9th. Cantor Fitzgerald reissued a “neutral” rating on shares of CVS Health in a research report on Friday, October 9th. JPMorgan Chase & Co. boosted their price objective on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. BMO Capital Markets set a $112.00 price objective on shares of CVS Health in a research note on Wednesday, September 9th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and issued a $112.00 target price on shares of CVS Health in a research report on Wednesday, September 9th. Twenty research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $107.80.

CVS Health Price Performance

NYSE CVS opened at $92.68 on Tuesday. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $118.53 billion, a PE ratio of 24.52, a price-to-earnings-growth ratio of 0.86 and a beta of 0.60. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The company has a 50 day moving average price of $91.68 and a two-hundred day moving average price of $93.33.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Investors of record on Thursday, October 22nd will be paid a $0.6650 dividend. The ex-dividend date is Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

About CVS Health

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.